Table 1 Baseline characteristics
Characteristic | All patients n = 49 | Patients without cholecystectomy after EGBS n = 24 | Patients with cholecystectomy after EGBS n = 25 |
|---|---|---|---|
Male: Female | 27: 22 | 13: 11 | 14: 11 |
Median age, years (range) | 75 (46–91) | 78 (46–91) | 73 (48–85) |
PS (ECOG) 0–2: 3–4 | 38: 11 | 14: 10 | 24: 1 |
Antithrombotic therapy | 23 (47%) | 13 (54%) | 10 (40%) |
Severity of cholecystitis | |||
Mild | 12 (24%) | 11 (46%) | 1 (4%) |
Moderate | 31 (63%) | 9 (38%) | 22 (88%) |
Severe | 6 (12%) | 4 (17%) | 2 (8%) |
Impaction of the gallstone | |||
In cystic duct | 5 (10%) | 4 (17%) | 1 (4%) |
In gall neck | 9 (16%) | 1 (4%) | 8 (32%) |
CBD stone | 17 (35%) | 10 (42%) | 7 (28%) |
Reason for EGBS | |||
CBD stone | 16 (33%) | 4 (17%) | 12 (48%) |
Antithrombotic therapy/coagulopathy | 16 (33%) | 6 (25%) | 10 (40%) |
Severe comorbidities | 10 (20%) | 4 (17%) | 6 (24%) |
Poor PS | 5 (10%) | 4 (17%) | 1 (4%) |
Other | 2 (4%) | 0 | 2 (8%) |